Li 2016.

Methods	8‐week parallel trial of paliperidone versus aripiprazole
Participants	Inclusion criteria: unknown (the only available details are in the abstract) Exclusion criteria: unknown Location/setting: unknown, but assumed to be China Number randomised: 62 (31 to each group) Number of withdrawals/dropouts: unknown (the only available details are in the abstract) Gender: details not provided Mean age: not known ‐ unable to find the full‐text paper IQ: not known ‐ unable to find the full‐text paper Baseline ABC‐I or other BoC: unknown Concurrent medications: unknown History of previous medications: unknown
Interventions	Intervention (paliperidone) for 8 weeks: details not reported Comparator (aripiprazole) for 8 weeks: details not reported
Outcomes	Primary outcomes: AEs Timing of outcome assessments: baseline, weeks 4,6, 8 (endpoint)
Notes	Study start date: details not reported Study end date: details not reported Source of funding: details not reported Conflicts of interest: details not reported